PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2024 Earnings Call Transcript November 7, 2024
PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, expectations were $-1.44.
Operator: Welcome to the PTC Third Quarter 2024 Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Again please be advised that today’s conference is being...
